Cytlimic is Drug Discovery in Japan that focus on cancer peptide vaccines business. Founded in 2016. They cover business area such as developer, immunotherapy, cancer, technology, patient.
2016
( 8 years old in 2024 )
Cancer Peptide Vaccines
-
2-15-19 Kamiosaki
MG Meguro Ekimae Building 7th Floor
Tokyo, Shinagawa-ku 141-0021
Japan
Private
developerimmunotherapycancertechnologypatient
* We use standard office opening hours in near Cytlimic's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cytlimic is Drug Discovery business from Japan that founded in 2016 (8 years old in 2024), Cytlimic business is focusing on Cancer Peptide Vaccines.
Cytlimic headquarter office and corporate office address is located in 2-15-19 Kamiosaki MG Meguro Ekimae Building 7th Floor Tokyo, Shinagawa-ku 141-0021 Japan.
Cytlimic was founded in Japan.
In 2024, Cytlimic is currently focus on cancer peptide vaccines sector.
Above is snippet of Google Trends for "cancer peptide vaccines" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cytlimic, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
